<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; winners</title>
	<atom:link href="http://www.tapanray.in/tag/winners/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Managing expectations of the emerging markets of the world, proactively, will differentiate winners from the rest, in the Global Pharmaceutical Industry.</title>
		<link>http://www.tapanray.in/managing-expectations-of-the-emerging-markets-of-the-world-proactively-will-differentiate-winners-from-the-rest-in-the-global-pharmaceutical-industry/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=managing-expectations-of-the-emerging-markets-of-the-world-proactively-will-differentiate-winners-from-the-rest-in-the-global-pharmaceutical-industry</link>
		<comments>http://www.tapanray.in/managing-expectations-of-the-emerging-markets-of-the-world-proactively-will-differentiate-winners-from-the-rest-in-the-global-pharmaceutical-industry/#comments</comments>
		<pubDate>Mon, 06 Jul 2009 00:00:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[differentiate]]></category>
		<category><![CDATA[emerging]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[proactively]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rest]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[Will]]></category>
		<category><![CDATA[winners]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=842</guid>
		<description><![CDATA[Change or Perish:In Mid 2007, PricewaterhouseCoopers (PwC) recommended to the research-based global pharmaceutical companies that for sustainable business performance they should move a part of their expenditure from marketing to research. They also recommended that the drug prices should be &#8230; <a href="http://www.tapanray.in/managing-expectations-of-the-emerging-markets-of-the-world-proactively-will-differentiate-winners-from-the-rest-in-the-global-pharmaceutical-industry/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/managing-expectations-of-the-emerging-markets-of-the-world-proactively-will-differentiate-winners-from-the-rest-in-the-global-pharmaceutical-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
